260 related articles for article (PubMed ID: 23294049)
1. Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study.
Sutter R; Marsch S; Fuhr P; Rüegg S
Epilepsia; 2013 Mar; 54(3):502-11. PubMed ID: 23294049
[TBL] [Abstract][Full Text] [Related]
2. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation.
Kowalski RG; Ziai WC; Rees RN; Werner JK; Kim G; Goodwin H; Geocadin RG
Crit Care Med; 2012 Sep; 40(9):2677-84. PubMed ID: 22732291
[TBL] [Abstract][Full Text] [Related]
3. Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study.
Sutter R; Tschudin-Sutter S; Grize L; Fuhr P; Bonten MJ; Widmer AF; Marsch S; Rüegg S
Epilepsia; 2012 Sep; 53(9):1489-97. PubMed ID: 22812603
[TBL] [Abstract][Full Text] [Related]
4. Predictors of outcome in refractory status epilepticus.
Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA
JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
[TBL] [Abstract][Full Text] [Related]
6. Refractory status epilepticus: a prospective observational study.
Novy J; Logroscino G; Rossetti AO
Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
[TBL] [Abstract][Full Text] [Related]
7. Acute-phase proteins and mortality in status epilepticus: a 5-year observational cohort study.
Sutter R; Grize L; Fuhr P; Rüegg S; Marsch S
Crit Care Med; 2013 Jun; 41(6):1526-33. PubMed ID: 23507720
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit.
Vooturi S; Jayalakshmi S; Sahu S; Mohandas S
Clin Neurol Neurosurg; 2014 Nov; 126():7-10. PubMed ID: 25194304
[TBL] [Abstract][Full Text] [Related]
9. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
Rossetti AO; Logroscino G; Bromfield EB
Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of nonconvulsive and subtle status epilepticus in an ICU of a tertiary care center: a three-year observational cohort study.
Rudin D; Grize L; Schindler C; Marsch S; Rüegg S; Sutter R
Epilepsy Res; 2011 Sep; 96(1-2):140-50. PubMed ID: 21676592
[TBL] [Abstract][Full Text] [Related]
12. Incidence and mortality of super-refractory status epilepticus in adults.
Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R
Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934
[TBL] [Abstract][Full Text] [Related]
13. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study.
Kantanen AM; Kälviäinen R; Parviainen I; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Reinikainen M
Crit Care; 2017 Mar; 21(1):71. PubMed ID: 28330483
[TBL] [Abstract][Full Text] [Related]
14. Aborted and refractory status epilepticus in children: a comparative analysis.
Lambrechtsen FA; Buchhalter JR
Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
[TBL] [Abstract][Full Text] [Related]
15. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
Dubey D; Bhoi SK; Kalita J; Misra UK
Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
[TBL] [Abstract][Full Text] [Related]
16. In-hospital mortality of generalized convulsive status epilepticus: a large US sample.
Koubeissi M; Alshekhlee A
Neurology; 2007 Aug; 69(9):886-93. PubMed ID: 17724291
[TBL] [Abstract][Full Text] [Related]
17. Functional outcome after convulsive status epilepticus.
Legriel S; Azoulay E; Resche-Rigon M; Lemiale V; Mourvillier B; Kouatchet A; Troché G; Wolf M; Galliot R; Dessertaine G; Combaux D; Jacobs F; Beuret P; Megarbane B; Carli P; Lambert Y; Bruneel F; Bedos JP
Crit Care Med; 2010 Dec; 38(12):2295-303. PubMed ID: 20890201
[TBL] [Abstract][Full Text] [Related]
18. Early predictors of refractory status epilepticus: an international two-center study.
Sutter R; Kaplan PW; Marsch S; Hammel EM; Rüegg S; Ziai WC
Eur J Neurol; 2015 Jan; 22(1):79-85. PubMed ID: 25104078
[TBL] [Abstract][Full Text] [Related]
19. Propofol treatment of refractory status epilepticus: a study of 31 episodes.
Rossetti AO; Reichhart MD; Schaller MD; Despland PA; Bogousslavsky J
Epilepsia; 2004 Jul; 45(7):757-63. PubMed ID: 15230698
[TBL] [Abstract][Full Text] [Related]
20. Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome.
Pandian JD; Cascino GD; So EL; Manno E; Fulgham JR
Arch Neurol; 2004 Jul; 61(7):1090-4. PubMed ID: 15262740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
